Bicocca Open Archive

Logo unimib boa
CHINELLO, CLIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.113
EU - Europa 6.991
AS - Asia 6.005
SA - Sud America 940
AF - Africa 92
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 12
Totale 26.170
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.810
SG - Singapore 2.009
IT - Italia 1.821
CN - Cina 1.661
DE - Germania 1.075
RU - Federazione Russa 936
HK - Hong Kong 919
BR - Brasile 776
SE - Svezia 743
IE - Irlanda 731
VN - Vietnam 721
GB - Regno Unito 375
AT - Austria 272
UA - Ucraina 247
CA - Canada 231
FR - Francia 178
IN - India 143
FI - Finlandia 139
KR - Corea 97
ID - Indonesia 96
DK - Danimarca 87
NL - Olanda 87
PL - Polonia 76
ES - Italia 64
AR - Argentina 59
TR - Turchia 52
JP - Giappone 51
BD - Bangladesh 46
BE - Belgio 45
ZA - Sudafrica 45
MX - Messico 43
EC - Ecuador 33
IQ - Iraq 28
CZ - Repubblica Ceca 20
IR - Iran 20
SA - Arabia Saudita 20
MA - Marocco 18
UZ - Uzbekistan 18
LT - Lituania 16
PK - Pakistan 16
AU - Australia 15
CO - Colombia 15
AE - Emirati Arabi Uniti 14
CH - Svizzera 14
IL - Israele 14
RO - Romania 14
VE - Venezuela 14
TW - Taiwan 12
PE - Perù 11
EU - Europa 10
UY - Uruguay 10
PH - Filippine 9
PY - Paraguay 8
TH - Thailandia 8
AZ - Azerbaigian 7
BG - Bulgaria 7
BO - Bolivia 7
CL - Cile 7
DO - Repubblica Dominicana 7
PA - Panama 7
GR - Grecia 6
KZ - Kazakistan 6
MY - Malesia 6
PT - Portogallo 6
AL - Albania 5
DZ - Algeria 5
EG - Egitto 5
JO - Giordania 5
KE - Kenya 5
LV - Lettonia 5
NO - Norvegia 5
HR - Croazia 4
KG - Kirghizistan 4
NP - Nepal 4
BN - Brunei Darussalam 3
LB - Libano 3
LU - Lussemburgo 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
ET - Etiopia 2
HN - Honduras 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BT - Bhutan 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
Totale 26.153
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.129
Singapore 1.343
Ashburn 1.209
Hong Kong 909
Fairfield 774
Milan 764
Chandler 722
Dublin 721
Frankfurt am Main 628
Woodbridge 626
Wilmington 532
Houston 528
Dallas 372
Dearborn 358
New York 341
Seattle 325
Santa Clara 310
Beijing 260
Cambridge 244
Vienna 243
Los Angeles 237
Jacksonville 233
Ho Chi Minh City 217
Hefei 191
Shanghai 180
Princeton 175
Hanoi 158
Nanjing 135
São Paulo 115
Moscow 88
Munich 86
Chicago 85
Seoul 81
Buffalo 69
Jakarta 68
Lawrence 63
Altamura 62
Fremont 59
Guangzhou 59
Kent 59
Nanchang 58
Helsinki 52
London 49
Dong Ket 48
Council Bluffs 47
Toronto 46
Warsaw 43
Brussels 42
Lachine 40
San Diego 40
Brooklyn 39
Denver 39
Ottawa 39
Montréal 38
Nuremberg 36
Montreal 34
Tokyo 34
Rome 32
Shenyang 32
Stockholm 31
Turku 31
Atlanta 30
Lissone 27
Changsha 26
Salt Lake City 26
Zhengzhou 26
Andover 25
Florence 25
Rio de Janeiro 25
Boston 24
Chennai 24
Johannesburg 24
Orem 24
Phoenix 24
San Francisco 24
Tianjin 24
Da Nang 23
Hebei 23
Düsseldorf 22
Amsterdam 20
Jinan 20
Pune 20
Caronno Pertusella 19
Falls Church 19
Haiphong 19
Kunming 19
Poplar 19
Boardman 18
Columbus 18
Ha Long 18
Hải Dương 18
Jiaxing 18
Ningbo 18
Norwalk 18
Brescia 17
Cinisello Balsamo 17
Madison 17
Manchester 17
Tashkent 17
Belo Horizonte 16
Totale 17.436
Salva come PNG Salva come JPEG
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 520
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 482
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 469
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 448
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 442
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 406
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 391
Differential protein profiling of renal cell carcinoma urinary exosomes 390
Urinary exosomes and diabetic nephropathy: a proteomic approach 385
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 369
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 362
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 360
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 358
The putative role of MALDI-MSI in the study of Membranous Nephropathy 349
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 347
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 341
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 337
Proteomics imaging and the kidney 331
The proteomic landscape of renal tumors 327
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 318
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 302
Mutual Information Optimization for Mass Spectra Data Alignment 300
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 299
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 298
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 296
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 295
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 295
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 292
Robust conclusions in mass spectrometry analysis 291
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 290
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 288
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 285
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 285
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 285
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 281
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 274
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 265
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 264
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 260
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 258
Proteome analysis in thyroid pathology 257
Tumor size, stage and grade alterations of urinary peptidome in RCC 256
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 254
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 252
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 244
Analysis of correlation structures in renal cell carcinoma patient data 241
A molecular imaging approach to individuate tumour infiltrating lymphocytes 240
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 235
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 235
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 234
Intraluminal proteome and peptidome of human urinary extracellular vesicles 234
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 231
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 228
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 228
AQP1 expression analysis in human diseases: Implications for proteomic characterization 226
Imaging mass spectrometry: a new tool for kidney disease investigations 225
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 224
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 223
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 220
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 217
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 212
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 211
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 209
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 209
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 208
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 206
Detection of high molecular weight proteins by MALDI imaging mass spectrometry 204
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 197
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 192
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 192
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 190
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 189
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 186
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 185
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 183
Poster: Characterization of distinguishing regions for renal cell carcinoma discrimination 183
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 182
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 180
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 176
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 176
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 176
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 173
Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry 173
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 168
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 165
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 162
Proteomic investigation of therapy induced senescence in cancer cells by a DIA-PASEF mass spectrometry approach 161
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 159
Immunoreattività e carcinoma renale 158
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 151
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 145
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 142
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 142
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 141
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 137
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 137
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 136
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 132
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 132
Identification of aberrant serum IgG glycoforms in Idiopathic membranous nephropathy 129
Totale 25.028
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.968
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.968
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.883 0 0 0 0 220 225 329 292 205 224 154 234
2021/20221.539 145 146 134 196 79 127 54 96 60 123 149 230
2022/20232.911 299 818 282 322 148 416 38 183 191 35 94 85
2023/20242.325 68 67 106 173 249 652 481 56 144 44 53 232
2024/20255.434 222 473 345 220 481 215 318 222 558 943 587 850
2025/20266.234 1.940 753 1.169 1.689 683 0 0 0 0 0 0 0
Totale 27.024